Support and Resources For Patients

If a healthcare provider has already determined that a Gilead treatment is right for a patient, then the Gilead Advancing Access® program is committed to helping them afford their medication every step of the way.

Financial Support

For patients who need assistance with their co-pays or paying for medication, Advancing Access is available to help match them to a program that best meets their financial needs based on particular circumstances and insurance situation and the eligibility criteria for the programs.

Advancing Access is available to help patients:

  • Lower their co-pay* and find other co-pay support, if eligible
  • Find and get financial support if they have government insurance
  • Find and get financial support if they are uninsured

*See specific terms and conditions at www.GileadAdvancingAccess.com

Insurance Support

Advancing Access is available to help guide patients through the process of understanding the type of insurance they have and alternative coverage if needed.

Advancing Access is available to help patients:

  • Identify and confirm coverage and benefits
  • When their insurance or coverage changes
  • When they need assistance understanding insurance

Find out more about the Gilead Advancing Access program:

Enroll at GileadAdvancingAccess.com by downloading and completing the enrollment form today.

Call .
Hours: Monday- Friday | 9 am to 8 pm ET

Important Safety Information

What is the most important information I should know about STRIBILD®?

STRIBILD can cause serious side effects:

  • Worsening of hepatitis B (HBV) infection. STRIBILD is not approved for the treatment of HBV. If you have both HIV-1 and HBV and stop taking STRIBILD, your HBV may suddenly get worse. Do not stop taking STRIBILD without first talking to your healthcare provider, as they will need to monitor your health.

What is STRIBILD?

STRIBILD is a prescription medicine used to treat HIV-1 in people 12 years and older who weigh at least 77 pounds. It can either be used in people who are starting HIV-1 treatment and have never taken HIV-1 medicines before, or in people who are replacing their current HIV-1 medicines and whose healthcare provider determines that they meet certain requirements. These include having an undetectable viral load (less than 50 copies/mL of virus in their blood) for 6 months or more on their current HIV-1 treatment. STRIBILD combines 4 medicines into 1 pill to be taken once a day with food. STRIBILD is a complete single tablet regimen and should not be used with other HIV-1 medicines.

STRIBILD does not cure HIV-1 infection or AIDS. To control HIV-1 infection and decrease HIV-related illnesses, you must keep taking STRIBILD. Ask your healthcare provider if you have questions about how to reduce the risk of passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.

CLICK TO EXPAND

Important Safety Information

What is the most important information I should know about STRIBILD®?

STRIBILD can cause serious side effects:

  • Worsening of hepatitis B (HBV) infection. STRIBILD is not approved for the treatment of HBV. If you have both HIV-1 and HBV and stop taking STRIBILD, your HBV may suddenly get worse. Do not stop taking STRIBILD without first talking to your healthcare provider, as they will need to monitor your health.